Key Market Indicators
Finnish Antidepressant Medicine Sales are projected to hit $45 million by 2028, maintaining the same figure as in 2023. This indicates a stagnant compound annual growth rate (CAGR) over the five-year period. Since 2003, Finland's market for antidepressants has seen a steady increase of 4% annually. In 2023, the country ranked 10th globally in terms of sales, with Austria narrowly ahead at $45 million. Leading the global rankings, Spain, Italy, and Australia secured the second, third, and fourth spots, respectively.
